• Home
  •  / Bristol-Myers Squibb

Bristol-Myers Squibb

OverviewSuggest Edit

Bristol-Myers Squibb is a biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. Its medicines help patients in disease areas such as oncology, cardiovascular, immunoscience, fibrosis, and others.
TypePublic
Founded1887
HQNew York, USMap
Websitebms.com
Employee Ratings3.9More
Culture scoreAMore
View Jobs (1,578)

Locations

Bristol-Myers Squibb is headquartered in
New York, United States

Location Map
All Locations (47)

Latest Updates

Employees (est.) (Dec 2019)30,000(+29%)
Job Openings1,578
Revenue (FY, 2019)$26.1 B(+16%)
Share Price (May 2020)$59.7

Key People/Management at Bristol-Myers Squibb

Beatrice Anduze-Faris

Beatrice Anduze-Faris

Head of Global Clinical Compliance & Continuous Improvement, Global Clinical Operations
Giovanni Caforio

Giovanni Caforio

Chairman of the Board and Chief Executive Officer
Peter J. Arduini

Peter J. Arduini

Director
Michaela Bowden

Michaela Bowden

Director, Translational Biology
Nadim Ahmed

Nadim Ahmed

Executive Vice President and President, Hematology
Sharon Cload

Sharon Cload

Vice President, Molecular Discovery Technologies
Show more

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in New York, Atlanta, Baltimore, Cambridge and in 42 other locations
New York, US (HQ)
430 E 29th St 14th Floor
Atlanta, US
950 East Paces Ferry Rd NE
Baltimore, US
Baltimore, MD, USA
Cambridge, US
100 Binney St
Columbus, US
999 Polaris Pkwy #100
Devens, US
38 Jackson Rd
Show all (47)

Bristol-Myers Squibb Financials and Metrics

Bristol-Myers Squibb Revenue

Bristol-Myers Squibb's revenue was reported to be $26.15 b in FY, 2019
USD

Revenue (Q1, 2020)

10.8b

Gross profit (Q1, 2020)

7.1b

Gross profit margin (Q1, 2020), %

66%

Net income (Q1, 2020)

(766.0m)

Market capitalization (29-May-2020)

135.1b

Closing stock price (29-May-2020)

59.7

Cash (31-Mar-2020)

15.8b

EV

166.0b
Bristol-Myers Squibb's current market capitalization is $135.1 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

16.4b15.9b16.6b19.4b20.8b22.6b26.1b

Revenue growth, %

(3%)4%17%7%9%

Cost of goods sold

4.6b3.9b3.9b4.9b6.1b8.1b

Gross profit

11.8b11.9b12.7b14.5b14.7b18.1b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

3.8b3.9b3.9b4.0b4.2b4.1b4.4b4.9b4.9b4.9b5.1b5.3b5.2b5.7b5.7b5.9b6.3b6.0b10.8b

Cost of goods sold

968.0m991.0m1.0b847.0m1.0b1.1b1.1b1.2b1.3b1.3b1.6b1.6b1.6b1.6b1.6b1.8b2.0b1.8b3.7b

Gross profit

2.8b2.9b2.9b3.2b3.2b3.0b3.3b3.7b3.6b3.7b3.6b3.7b3.6b4.1b4.0b4.1b4.3b4.2b7.1b

Gross profit Margin, %

75%75%74%79%76%73%76%75%73%74%70%70%69%72%71%69%68%70%66%
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

5.0b5.8b1.7b3.6b5.6b2.4b4.2b5.4b6.9b12.3b

Accounts Receivable

2.0b2.3b1.7b6.3b6.0b7.7b

Prepaid Expenses

252.0m258.0m355.0m576.0m1.1b2.0b

Inventories

1.2b1.4b1.7b1.5b1.6b1.2b1.2b1.2b1.2b4.3b
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

5.1b5.9b7.6b3.4b3.7b4.5b2.3b2.8b1.5b1.4b1.8b1.8b5.2b4.3b4.9b6.3b4.2b4.0b2.6b2.9b3.4b3.9b3.5b4.6b5.3b5.0b5.4b7.3b28.4b30.5b15.8b

Accounts Receivable

3.5b1.8b2.0b2.0b2.1b2.2b2.3b1.6b1.7b1.8b1.9b3.7b3.3b3.3b3.3b3.5b3.7b3.9b5.0b5.6b5.6b5.5b5.8b5.9b5.7b5.6b5.9b5.7b5.7b5.5b8.3b

Prepaid Expenses

268.0m296.0m292.0m451.0m420.0m356.0m500.0m455.0m423.0m616.0m536.0m556.0m538.0m512.0m482.0m538.0m502.0m529.0m615.0m588.0m565.0m628.0m820.0m754.0m965.0m998.0m886.0m1.3b1.4b947.0m

Inventories

1.3b1.3b1.4b1.3b1.5b1.4b1.5b1.5b1.7b1.8b1.8b1.6b1.7b1.7b1.6b1.4b1.3b1.1b1.3b1.4b1.5b1.4b1.2b1.3b1.2b1.2b1.3b1.3b1.3b1.2b2.8b
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

3.1b3.7b2.0b2.6b2.0b1.6b4.5b975.0m4.9b3.5b

Depreciation and Amortization

473.0m448.0m681.0m789.0m637.0m1.7b

Inventories

156.0m(193.0m)(103.0m)(45.0m)(254.0m)97.0m(152.0m)(29.0m)(216.0m)463.0m

Accounts Payable

315.0m593.0m(232.0m)412.0m(44.0m)(919.0m)104.0m320.0m(59.0m)229.0m
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

1.1b1.7b2.6b986.0m1.9b2.9b1.1b1.7b1.0b609.0m1.1b1.8b936.0m1.3b2.0b1.2b1.1b1.8b1.2b2.4b3.6b1.5b2.4b3.3b1.5b1.9b3.8b1.7b3.2b4.5b(766.0m)

Depreciation and Amortization

187.0m246.0m348.0m117.0m228.0m333.0m85.0m175.0m482.0m213.0m402.0m582.0m137.0m252.0m364.0m104.0m195.0m300.0m65.0m155.0m260.0m240.0m404.0m592.0m143.0m300.0m465.0m223.0m443.0m510.0m2.6b

Inventories

25.0m(12.0m)37.0m(84.0m)(246.0m)(150.0m)(68.0m)(170.0m)(135.0m)(163.0m)(173.0m)(8.0m)(144.0m)(157.0m)(162.0m)51.0m162.0m231.0m(44.0m)(111.0m)(107.0m)(71.0m)(58.0m)7.0m(4.0m)(122.0m)(152.0m)35.0m28.0m(7.0m)1.4b

Accounts Payable

119.0m54.0m77.0m62.0m412.0m309.0m32.0m(222.0m)(321.0m)(53.0m)203.0m301.0m(12.0m)(112.0m)63.0m(83.0m)(618.0m)(1.2b)(77.0m)(36.0m)(142.0m)(114.0m)(85.0m)63.0m(241.0m)(101.0m)(186.0m)136.0m156.0m48.0m703.0m
show all
USDY, 2020

EV/CFO

42.6 x

Financial Leverage

2.6 x
Show all financial metrics

Bristol-Myers Squibb Operating Metrics

FY, 2015FY, 2016

Phase III Trials Products

2 8

Projects in R&D Pipeline

32 44
Show all operating metrics

Bristol-Myers Squibb Acquisitions / Subsidiaries

Company NameDateDeal Size
CelgeneJanuary 03, 2019$74 b

Bristol-Myers Squibb Online and Social Media Presence

Bristol-Myers Squibb's Trends

Embed Graph

Bristol-Myers Squibb Company Culture

  • Overall Culture

    A

    76/100

  • CEO Rating

    A+

    81/100

  • Compensation

    A+

    85/100

  • Diversity

    A+

    79/100

Learn more on Comparably

 Bristol-Myers Squibb Frequently Asked Questions

  • When was Bristol-Myers Squibb founded?

    Bristol-Myers Squibb was founded in 1887.

  • Who are Bristol-Myers Squibb key executives?

    Bristol-Myers Squibb's key executives are Beatrice Anduze-Faris, Giovanni Caforio and Peter J. Arduini.

  • How many employees does Bristol-Myers Squibb have?

    Bristol-Myers Squibb has 30,000 employees.

  • What is Bristol-Myers Squibb revenue?

    Latest Bristol-Myers Squibb annual revenue is $26.1 b.

  • What is Bristol-Myers Squibb revenue per employee?

    Latest Bristol-Myers Squibb revenue per employee is $871.5 k.

  • Who are Bristol-Myers Squibb competitors?

    Competitors of Bristol-Myers Squibb include AstraZeneca, Eli Lilly and Novartis.

  • Where is Bristol-Myers Squibb headquarters?

    Bristol-Myers Squibb headquarters is located at 430 E 29th St 14th Floor, New York.

  • Where are Bristol-Myers Squibb offices?

    Bristol-Myers Squibb has offices in New York, Atlanta, Baltimore, Cambridge and in 42 other locations.

  • How many offices does Bristol-Myers Squibb have?

    Bristol-Myers Squibb has 47 offices.